• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

    18.95 +1.77 (+10.30%)
    Streaming Delayed Price Updated: 1:27 PM EDT, Aug 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 791,966
    Open 19.25
    Bid (Size) 18.91 (2)
    Ask (Size) 18.97 (12)
    Prev. Close 17.18
    Today's Range 18.32 - 19.51
    52wk Range 14.57 - 25.11
    Shares Outstanding 29,926,846
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
     
    Via Benzinga
    These stocks that are showing activity before the opening bell on Friday.
    As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
    Via Chartmill

    Performance

    YTD
    +2.9%
    +2.9%
    1 Month
    -4.8%
    -4.8%
    3 Month
    +9.9%
    +9.9%
    6 Month
    +11.5%
    +11.5%
    1 Year
    -20.8%
    -20.8%

    More News

    Read More
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Fulgent Genetics Earnings Preview
    Via Benzinga
    Fulgent Reports Second Quarter 2025 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Earnings Scheduled For August 1, 2025
    Via Benzinga
    Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM
    From Fulgent Genetics, Inc.
    Via Business Wire
    Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
    From Fulgent Genetics, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
    From Pomerantz LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Frequently Asked Questions

    Is Fulgent Genetics, Inc. - Common Stock publicly traded?
    Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
    What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
    Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
    The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
    What is the current price of Fulgent Genetics, Inc. - Common Stock?
    The current price of Fulgent Genetics, Inc. - Common Stock is 18.95
    When was Fulgent Genetics, Inc. - Common Stock last traded?
    The last trade of Fulgent Genetics, Inc. - Common Stock was at 08/01/25 01:27 PM ET
    What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
    The market capitalization of Fulgent Genetics, Inc. - Common Stock is 567.11M
    How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
    Fulgent Genetics, Inc. - Common Stock has 567M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.